{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:46:06Z","timestamp":1784389566825,"version":"3.55.0"},"reference-count":152,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) pathology begins decades before the onset of clinical symptoms. It is recognized as a clinicobiological entity, being detectable in vivo independently of the clinical stage by means of pathophysiological biomarkers. Accordingly, neuropathological studies that were carried out on healthy elderly subjects, with or without subjective experience of cognitive decline, reported evidence of AD pathology in a high proportion of cases. At present, mild cognitive impairment (MCI) represents the only clinically diagnosed pre-dementia stage. Several attempts have been carried out to detect AD as early as possible, when subtle cognitive alterations, still not fulfilling MCI criteria, appear. Importantly, pre-MCI individuals showing the positivity of pathophysiological AD biomarkers show a risk of progression similar to MCI patients. In view of successful treatment with disease modifying agents, in a clinical setting, a timely diagnosis is mandatory. In clinical routine, biomarkers assessment should be taken into consideration whenever a subject with subtle cognitive deficits (pre-MCI), who is aware of his\/her decline, requests to know the cause of such disturbances. In this review, we report the available neuropsychological and biomarkers data that characterize the pre-MCI patients, thus proposing pre-MCI as the first clinical manifestation of AD.<\/jats:p>","DOI":"10.3390\/brainsci9090213","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:38:23Z","timestamp":1566794303000},"page":"213","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Biomarker-Based Signature of Alzheimer\u2019s Disease in Pre-MCI Individuals"],"prefix":"10.3390","volume":"9","author":[{"given":"Elena","family":"Chipi","sequence":"first","affiliation":[{"name":"Center for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, Department of Medicine, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Salvadori","sequence":"additional","affiliation":[{"name":"Center for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, Department of Medicine, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Farotti","sequence":"additional","affiliation":[{"name":"Center for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, Department of Medicine, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-3967","authenticated-orcid":false,"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[{"name":"Center for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, Department of Medicine, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer Dement."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer Dement."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer Dement."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer Dement."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment--beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer Dement."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer\u2019s disease: A new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer Dement."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-018-0459-7","article-title":"Prevalence and risk of progression of preclinical Alzheimer\u2019s disease stages: A systematic review and meta-analysis","volume":"11","author":"Parnetti","year":"2019","journal-title":"Alzheimer Res. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/01.wnl.0000228231.26111.6e","article-title":"Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI","volume":"67","author":"Storandt","year":"2006","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dadm.2016.09.002","article-title":"Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: A meta-analysis","volume":"6","author":"Baker","year":"2017","journal-title":"Alzheimer Dement."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/JGP.0b013e3182107c69","article-title":"Pre-MCI and MCI: Neuropsychological, clinical, and imaging features and progression rates","volume":"19","author":"Duara","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jalz.2011.03.002","article-title":"An investigation of PreMCI: Subtypes and longitudinal outcomes","volume":"8","author":"Loewenstein","year":"2012","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimer Dement."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2009.10.002","article-title":"Outcome over seven years of healthy adults with and without subjective cognitive impairment","volume":"6","author":"Reisberg","year":"2010","journal-title":"Alzheimer Dement."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dadm.2015.02.005","article-title":"Cognitive performance before and after the onset of subjective cognitivedecline in old age","volume":"1","author":"Koppara","year":"2015","journal-title":"Alzheimer Dement."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep44368","article-title":"A \u201cDisease Severity Index\u201d to identify individuals with Subjective Memory Decline who will progress to mild cognitive impairment or dementia","volume":"7","author":"Ferreira","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-017-0314-2","article-title":"Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer\u2019s disease (DELCODE)","volume":"10","author":"Jessen","year":"2018","journal-title":"Alzheimer Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of Dementia by Subjective Memory Impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/acps.12336","article-title":"Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis","volume":"130","author":"Mitchell","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.0000000000001712","article-title":"Subjective cognitive concerns, amyloid-\u03b2, and neurodegeneration in clinically normal elderly","volume":"85","author":"Amariglio","year":"2015","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jalz.2015.12.013","article-title":"Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer\u2019s disease","volume":"12","author":"Buckley","year":"2016","journal-title":"Alzheimer Dement."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.trci.2018.08.005","article-title":"Amyloid-associated increases in longitudinal report of subjective cognitive complaints","volume":"4","author":"Amariglio","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","article-title":"Subjective cognitive decline and rates of incident Alzheimer\u2019s disease and non\u2013Alzheimer\u2019s disease dementia","volume":"15","author":"Slot","year":"2019","journal-title":"Alzheimer Dement."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","article-title":"Implementation of subjective cognitive decline criteria in research studies","volume":"13","author":"Molinuevo","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","article-title":"Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u03b2","volume":"13","author":"Mormino","year":"2017","journal-title":"Alzheimer Dement."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.3233\/JAD-150154","article-title":"Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies","volume":"48","author":"Rabin","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-161252","article-title":"Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"58","author":"Wolfsgruber","year":"2017","journal-title":"J. Alzheimer Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2013.15.1\/kjellinger","article-title":"Neuropathological approaches to cerebral aging and neuroplasticity","volume":"15","author":"Jellinger","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awt362","article-title":"Biochemical stages of amyloid-\u03b2 peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease","volume":"137","author":"Kosterin","year":"2014","journal-title":"Brain"},{"key":"ref_35","first-page":"a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Frosch","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00401-016-1546-0","article-title":"Phosphorylation of the amyloid \u03b2-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity","volume":"131","author":"Kumar","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1093\/brain\/awr308","article-title":"Neocortical and hippocampal amyloid-\u03b2 and tau measures associate with dementia in the oldest-old","volume":"134","author":"Robinson","year":"2011","journal-title":"Brain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2013.00050","article-title":"Relation of neuropathology with cognitive decline among older persons without dementia","volume":"5","author":"Boyle","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jalz.2015.05.018","article-title":"[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer\u2019s disease: Specific detection of advanced phases of amyloid-\u03b2 pathology","volume":"11","author":"Thal","year":"2015","journal-title":"Alzheimer Dement."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of Nondemented Aging: Presumptive Evidence for Preclinical Alzheimer Disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3233\/JAD-2011-102133","article-title":"Prediction of Preclinical Alzheimer\u2019s Disease: Longitudinal Rates of Change in Cognition","volume":"25","author":"Riley","year":"2011","journal-title":"J. Alzheimer Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.10.012","article-title":"Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment","volume":"37","author":"Mufson","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1212\/WNL.0000000000000650","article-title":"Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology","volume":"83","author":"Monsell","year":"2014","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2011.02.018","article-title":"Preclinical AD Workgroup staging: Pathological correlates and potential challenges","volume":"33","author":"Jicha","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1017\/S1355617716000928","article-title":"Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer\u2019s Disease","volume":"22","author":"Edmonds","year":"2016","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/01.wnl.0000242734.16663.09","article-title":"Memory complaints are related to Alzheimer disease pathology in older persons","volume":"67","author":"Barnes","year":"2006","journal-title":"Neurology"},{"key":"ref_48","first-page":"13","article-title":"Self-Reported Memory Complaints: A Comparison of Demented and Unimpaired Outcomes","volume":"3","author":"Kryscio","year":"2016","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.0000000000000856","article-title":"Self-reported memory complaints: Implications from a longitudinal cohort with autopsies","volume":"83","author":"Kryscio","year":"2014","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2017.04.004","article-title":"Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease","volume":"56","author":"Schindler","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: A longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-150128","article-title":"Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer\u2019s Disease","volume":"47","author":"Edmonds","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2016.12.003","article-title":"Preclinical Alzheimer\u2019s disease: A systematic review of the cohorts underlying the concept","volume":"13","author":"Epelbaum","year":"2017","journal-title":"Alzheimer Dement."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WAD.0b013e3181cfc78b","article-title":"Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care","volume":"24","author":"Grober","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.0000000000003812","article-title":"Cued memory decline in biomarker-defined preclinical Alzheimer disease","volume":"88","author":"Papp","year":"2017","journal-title":"Neurology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-161173","article-title":"Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer\u2019s Disease Stage 1","volume":"58","author":"Valech","year":"2017","journal-title":"J. Alzheimer Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/alzrt222","article-title":"Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer\u2019s disease: A selective review","volume":"5","author":"Rentz","year":"2013","journal-title":"Alzheimer Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: Measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2014.02.002","article-title":"An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer\u2019s disease","volume":"10","author":"Langbaum","year":"2014","journal-title":"Alzheimer Dement."},{"key":"ref_60","first-page":"19","article-title":"Sensitivity of composite scores to amyloid burden in preclinical Alzheimer\u2019s disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score","volume":"2","author":"Lim","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.13m08927","article-title":"The Alzheimer\u2019s Prevention Initiative composite cognitive test score: Sample size estimates for the evaluation of preclinical Alzheimer\u2019s disease treatments in presenilin 1 E280A mutation carriers","volume":"75","author":"Ayutyanont","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"ref_62","first-page":"3","article-title":"Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries","volume":"4","author":"Buckley","year":"2017","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/brain\/111.3.695","article-title":"A comparative study of visuospatial memory and learning in alzheimer-type dementia and parkinson\u2019s disease","volume":"111","author":"Sahakian","year":"1988","journal-title":"Brain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.neuropsychologia.2011.03.037","article-title":"Hippocampal dysfunction in patients with mild cognitive impairment: A functional neuroimaging study of a visuospatial paired associates learning task","volume":"49","author":"Pironti","year":"2011","journal-title":"Neuropsychologia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/gps.1180","article-title":"Early detection of Alzheimer\u2019s disease (AD) using the CANTAB Paired Associates Learning Test","volume":"19","author":"Coen","year":"2004","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000342116","article-title":"Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and alzheimer\u2019s disease","volume":"34","author":"Junkkila","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1017\/S1355617716000722","article-title":"Computerized cognitive tests are associated with biomarkers of Alzheimer\u2019s disease in cognitively normal individuals 10 years prior","volume":"22","author":"Soldan","year":"2016","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-180525","article-title":"Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer\u2019s Disease Biomarker and Mild Cognitive Impairment Diagnoses","volume":"69","author":"Nation","year":"2019","journal-title":"J. Alzheimer Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5114\/fn.2018.76612","article-title":"The Erlangen Score Algorithm in the diagnosis and prediction of the progression from subjective cognitive decline and mild cognitive impairment to Alzheimer-type dementia","volume":"56","author":"Barczak","year":"2018","journal-title":"Folia Neuropathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamaneurol.2014.3375","article-title":"Tracking early decline in cognitive function in older individuals at risk for Alzheimer\u2019s disease dementia: The Alzheimer\u2019s Disease Cooperative Study Cognitive Function Instrument HHS Public Access","volume":"72","author":"Amariglio","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chipi, E., Montanucci, C., Eusebi, P., D\u2019Andrea, K., Biscetti, L., Calabresi, P., and Parnetti, L. (2019). The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: Results at 1-year follow-up. Neurol. Sci.","DOI":"10.1007\/s10072-019-03960-x"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): A longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons","volume":"317","author":"Donohue","year":"2017","journal-title":"JAMA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","article-title":"Preclinical AD predicts decline in memory and executive functions in subjective complaints","volume":"81","author":"Smits","year":"2013","journal-title":"Neurology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jalz.2012.08.004","article-title":"Cerebrospinal fluid A\u03b242 is the best predictor of clinical progression in patients with subjective complaints","volume":"9","author":"Visser","year":"2013","journal-title":"Alzheimer Dement."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","article-title":"The clinical use of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: A consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative","volume":"10","author":"Molinuevo","year":"2014","journal-title":"Alzheimer Dement."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A Review of Fluid Biomarkers for Alzheimer\u2019s Disease: Moving from CSF to Blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00259-015-3156-9","article-title":"Amyloid imaging in cognitively normal older adults: Comparison between 18 F-flutemetamol and 11 C-Pittsburgh compound B","volume":"43","author":"Adamczuk","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3233\/JAD-170511","article-title":"Alzheimer\u2019s Disease Biomarkers and Future Decline in Cognitive Normal Older Adults","volume":"60","author":"Dumurgier","year":"2017","journal-title":"J. Alzheimer Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2019.03.001","article-title":"The added value of A\u03b242\/A\u03b240 in the CSF signature for routine diagnostics of Alzheimer\u2019s disease","volume":"494","author":"Biscetti","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal Fluid A\u03b242\/40 Corresponds Better than A\u03b242 to Amyloid PET in Alzheimer\u2019s Disease","volume":"55","author":"Lewczuk","year":"2017","journal-title":"J. Alzheimer Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13760-017-0816-5","article-title":"Alzheimer\u2019s disease CSF biomarkers: Clinical indications and rational use","volume":"117","author":"Niemantsverdriet","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Harrington, M.G., Chiang, J., Pogoda, J.M., Gomez, M., Thomas, K., Marion, S.D., Miller, K.J., Siddarth, P., Yi, X., and Zhou, F. (2013). Executive Function Changes before Memory in Preclinical Alzheimer\u2019s Pathology: A Prospective, Cross-Sectional, Case Control Study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079378"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/brain\/awv199","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarker in cognitively normal subjects","volume":"138","author":"Toledo","year":"2015","journal-title":"Brain"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-160176","article-title":"Association between Cerebrospinal Fluid Biomarkers for Alzheimer\u2019s Disease: APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer\u2019s Disease","volume":"54","author":"Mandecka","year":"2016","journal-title":"J. Alzheimer Dis."},{"key":"ref_89","first-page":"96","article-title":"Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer\u2019s disease in a memory clinic sample","volume":"8","author":"Rolstad","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1474-4422(09)70139-5","article-title":"Prevalence and prognostic value of CSF markers of Alzheimer\u2019s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study","volume":"8","author":"Visser","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000354188","article-title":"Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers","volume":"3","author":"Grambaite","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2017.10.008","article-title":"CSF A\u03b21\u201342, but not p-Tau181, differentiates aMCI from SCI","volume":"1678","author":"Rizzi","year":"2018","journal-title":"Brain Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-018-0463-y","article-title":"Prevalence of abnormal Alzheimer\u2019s disease biomarkers in patients with subjective cognitive decline: Cross-sectional comparison of three European memory clinic samples","volume":"11","author":"Wolfsgruber","year":"2019","journal-title":"Alzheimer Res. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2010-101422","article-title":"Cerebrospinal Fluid Biomarkers and Memory Present Distinct Associations along the Continuum from Healthy Subjects to AD Patients","volume":"23","author":"Rami","year":"2011","journal-title":"J. Alzheimer Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JAD-2011-110038","article-title":"Amyloid-\u03b242 is Associated with Cognitive Impairment in Healthy Elderly and Subjective Cognitive Impairment","volume":"26","author":"Rolstad","year":"2011","journal-title":"J. Alzheimer Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1037\/neu0000246","article-title":"Biomarker validation of a decline in semantic processing in preclinical alzheimer\u2019s disease","volume":"30","author":"Papp","year":"2016","journal-title":"Neuropsychology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age","volume":"72","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/01.wnl.0000435558.98447.17","article-title":"CSF biomarker changes precede symptom onset of mild cognitive impairment","volume":"81","author":"Moghekar","year":"2013","journal-title":"Neurology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.dadm.2015.09.002","article-title":"Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer\u2019s disease: A prospective 9-year study","volume":"1","author":"Stomrud","year":"2015","journal-title":"Alzheimer Dement."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.neuropsychologia.2012.08.011","article-title":"Subjective cognitive complaints and amyloid burden in cognitively normal older individuals","volume":"50","author":"Amariglio","year":"2012","journal-title":"Neuropsychologia"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneurol.2011.666","article-title":"Subjective cognition and amyloid deposition imaging: A Pittsburgh Compound B positron emission tomography study in normal elderly individuals","volume":"69","author":"Perrotin","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.3233\/JAD-150113","article-title":"Amyloid-\u03b2 imaging in older adults presenting to a memory clinic with subjective cognitive decline: A pilot study","volume":"48","author":"Snitz","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/WNL.0000000000003889","article-title":"Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden","volume":"88","author":"Vannini","year":"2017","journal-title":"Neurology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-140678","article-title":"Amyloid-\u03b2 related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults","volume":"43","author":"Hollands","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","article-title":"Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community","volume":"73","author":"Petersen","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","article-title":"Association of cerebral amyloid-\u03b2 Aggregation with cognitive functioning in persons without dementia","volume":"75","author":"Jansen","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/brain\/awq383","article-title":"Independent contribution of temporal \u03b2-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer\u2019s disease","volume":"134","author":"Villemagne","year":"2011","journal-title":"Brain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal Assessment of A\u03b2 and Cognition in Aging and Alzheimer Disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","article-title":"Meta-analysis of amyloid-cognition relations in cognitively normal older adults","volume":"80","author":"Hedden","year":"2013","journal-title":"Neurology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/brain\/awu271","article-title":"Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/brain\/awt286","article-title":"Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer\u2019s disease","volume":"137","author":"Lim","year":"2013","journal-title":"Brain"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neurobiolaging.2019.02.020","article-title":"Amyloid PET and cognitive decline in cognitively normal individuals: The SCIENCe project","volume":"79","author":"Timmers","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0000000000004627","article-title":"Subjective cognitive decline and \u03b2-amyloid burden predict cognitive change in healthy elderly","volume":"89","author":"Vogel","year":"2017","journal-title":"Neurology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nicl.2013.10.018","article-title":"Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects","volume":"4","author":"Ewers","year":"2014","journal-title":"NeuroImage Clin."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-121684","article-title":"Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints","volume":"39","author":"Brugnolo","year":"2014","journal-title":"J. Alzheimer Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jagp.2017.02.002","article-title":"Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints","volume":"25","author":"Rognoni","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","article-title":"Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment","volume":"79","author":"Scheef","year":"2012","journal-title":"Neurology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-151084","article-title":"Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults","volume":"52","author":"Shah","year":"2016","journal-title":"J. Alzheimer Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.biopsych.2007.05.030","article-title":"Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints","volume":"63","author":"Mosconi","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0284185114566088","article-title":"Alteration patterns of brain glucose metabolism: Comparisons of healthy controls, subjective memory impairment and mild cognitive impairment","volume":"57","author":"Song","year":"2016","journal-title":"Acta Radiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1037\/a0020859","article-title":"Subjective Cognitive Complaints and Longitudinal Changes in Memory and Brain Function","volume":"25","author":"Hohman","year":"2011","journal-title":"Neuropsychology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2967\/jnumed.112.113928","article-title":"Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project","volume":"54","author":"Morbelli","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2013.182","article-title":"Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with \u03b2-amyloidosis","volume":"70","author":"Knopman","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182166e96","article-title":"Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults","volume":"76","author":"Dickerson","year":"2011","journal-title":"Neurology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archneurol.2011.167","article-title":"The dynamics of cortical and hippocampal atrophy in Alzheimer disease","volume":"68","author":"Sabuncu","year":"2011","journal-title":"Arch Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"825.e25","DOI":"10.1016\/j.neurobiolaging.2011.05.018","article-title":"Structural MRI changes detectable up to ten years before clinical Alzheimer\u2019s disease","volume":"33","author":"Tondelli","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2013.05.1764","article-title":"Gray matter atrophy pattern in elderly with subjective memory impairment","volume":"10","author":"Peter","year":"2014","journal-title":"Alzheimer Dement."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/cercor\/bht017","article-title":"Association of gray matter atrophy with age, \u03b2-amyloid, and cognition in aging","volume":"24","author":"Oh","year":"2014","journal-title":"Cereb. Cortex"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nicl.2014.04.009","article-title":"Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer\u2019s disease","volume":"5","author":"Younes","year":"2014","journal-title":"NeuroImage Clin."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.dadm.2014.11.010","article-title":"Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD","volume":"1","author":"Schultz","year":"2015","journal-title":"Alzheimer Dement."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and \u03b2-amyloid deposition in Alzheimer disease","volume":"67","author":"Villemagne","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-\u03b2 Associated Cortical Thinning in Clinically Normal Elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer\u2019s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0b013e31823efc6c","article-title":"MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults","volume":"78","author":"Dickerson","year":"2012","journal-title":"Neurology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","article-title":"A default mode of brain function","volume":"98","author":"Raichle","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1073\/pnas.0135058100","article-title":"Functional connectivity in the resting brain: A network analysis of the default mode hypothesis","volume":"100","author":"Greicius","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: Evidence from functional MRI","volume":"101","author":"Greicius","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","article-title":"The brain\u2019s default network: Anatomy, function, and relevance to disease","volume":"1124","author":"Buckner","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.3233\/JAD-150087","article-title":"Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline","volume":"48","author":"Perrotin","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jalz.2016.08.010","article-title":"Longitudinal brain structural changes in preclinical Alzheimer\u2019s disease","volume":"13","author":"Pegueroles","year":"2017","journal-title":"Alzheimer Dement."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Desikan, R.S., Sabuncu, M.R., Schmansky, N.J., Reuter, M., Cabral, H.J., Hess, C.P., Weiner, M.W., Biffi, A., Anderson, C.D., and Rosand, J. (2010). Selective disruption of the cerebral neocortex in alzheimer\u2019s disease. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012853"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.22509","article-title":"Amyloid-\u03b2 associated volume loss occurs only in the presence of phospho-tau","volume":"70","author":"Desikan","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nicl.2017.08.022","article-title":"Progressive medial temporal lobe atrophy during preclinical Alzheimer\u2019s disease","volume":"16","author":"Pettigrew","year":"2017","journal-title":"NeuroImage Clin."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid \u00df-amyloid 1-42 values have thicker cortex in Alzheimer\u2019s disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-142322","article-title":"Cortical Thinning in Individuals with Subjective Memory Impairment","volume":"45","author":"Meiberth","year":"2015","journal-title":"J. Alzheimer Dis."},{"key":"ref_147","first-page":"13","article-title":"Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer\u2019s Disease: A Structural Imaging Study","volume":"13","author":"Zhao","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.dadm.2016.10.007","article-title":"Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline","volume":"5","author":"Verfaillie","year":"2016","journal-title":"Alzheimer Dement."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/brain.2013.0144","article-title":"Increased Functional Connectivity and Brain Atrophy in Elderly with Subjective Memory Complaints","volume":"3","author":"Hafkemeijer","year":"2013","journal-title":"Brain Connect."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1017\/S1041610216002349","article-title":"Hippocampal and entorhinal structures in subjective memory impairment: A combined MRI volumetric and DTI study","volume":"29","author":"Ryu","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/hbm.24065","article-title":"A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline","volume":"39","author":"Verfaillie","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11065-017-9345-5","article-title":"Detectable Neuropsychological Differences in Early Preclinical Alzheimer\u2019s Disease: A Meta-Analysis","volume":"27","author":"Nguyen","year":"2017","journal-title":"Neuropsychol. Rev."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/9\/9\/213\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:23Z","timestamp":1760188403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/9\/9\/213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":152,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["brainsci9090213"],"URL":"https:\/\/doi.org\/10.3390\/brainsci9090213","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]}}}